Knowing the tumour microenvironment to optimise immunotherapy.

M C Merlano, A Abbona, N Denaro, O Garrone

Journal: Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 2019;39(1):2-8

PMID: 30936573

Free Full Text on PubMed Central View on PubMed

Abstract

Address: Medical Oncology Dept, S. Croce & Carle Teaching Hospital, Cuneo, Itally.; ARCO Foundation, Cuneo, Italy.; ARCO Foundation, Cuneo, Italy.; Medical Oncology Dept, S. Croce & Carle Teaching Hospital, Cuneo, Itally.; Medical Oncology Dept, S. Croce & Carle Teaching Hospital, Cuneo, Itally.; Breast Unit, Medical Oncology, S. Croce & Carle Teaching Hospital, Cuneo, Italy.

DOI: 10.14639/0392-100X-2481

Link outs

Free resources

Full Text Sources:

Miscellaneous:

https://assays.cancer.gov/CPTAC-1275

MeSH Terms: Antineoplastic Agents, Humans, Immunotherapy, NK Cell Lectin-Like Receptor Subfamily C, Neoplasms, Programmed Cell Death 1 Receptor, STAT3 Transcription Factor, Toll-Like Receptors, Tumor Microenvironment